1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Pharmacy Benefit Manager Sofware Market
3.1.1. Increasing vertical PBM-vendor integration to transform pharmacy benefit market
3.1.2. Contracting model preferred continues to evolve, moving away from rebate system
3.1.3. A large number of M&A deals
3.1.4. Healthcare investors keeping an eye on this tren
3.1.5. Revenue Growth to be Fueled by the Growing Need for Advanced Drug Utilization Programs
3.2. Attractive Opportunities in the Pharmacy Benefit Manager Sofware Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Need to improves patient?s safety by avoiding the health risks associated with medication use
4.2.1.2. Improves the adherence to drug prescription reasoning and adaptation of drug formulations
4.2.1.3. Need to supports health professionals by providing the scientific evidence to improve the medication management
4.2.2. Restraints
4.2.2.1. Stringent regulations to cut back rebates
4.2.3. Opportunities
4.2.3.1. Rise in Value-based contracts with Pharma manufacturers
4.2.3.2. Big e-commerce vendors pharmacy distribution and reimbursement market
4.2.4. Challenges
4.2.4.1. Legal uncertainty surrounds the PBM industry
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Adoption Trends
4.4.2. Product Capability Analysis
5. Global Pharmacy Benefit Manager Sofware Market: Type Estimates & Trend Analysis
5.1. Introduction
5.2. Integrated
5.3. Standalone
6. Global Pharmacy Benefit Manager Sofware Market: Operataion Estimates & Trend Analysis
6.1. Introduction
6.2. Benefit Plan Design and Consultation
6.3. Drug Formulary Management
6.4. Retail Pharmacy Services
6.5. Specialty Pharmacy Services
7. Global Pharmacy Benefit Manager Sofware Market: End-user Estimates & Trend Analysis
7.1. Introduction
7.2. Government
7.3. Insurance Providers
7.4. Patient
7.5. Pharmacy
8. Global Pharmacy Benefit Manager Sofware Market: Deployment Estimates & Trend Analysis
8.1. Introduction
8.2. On-Cloud
8.3. On-Premise
9. Global Pharmacy Benefit Manager Sofware Market: Geographic Estimates & Trend Analysis
9.1. Introduction
9.2. Americas
9.3. Europe, Middle East & Africa
9.4. Asia-Pacific
10. Competitive Landscape
10.1. 360iResearch FPNV Positioning Matrix
10.2. Market Vendor Ranking Analysis
10.3. Competitive News Feed Analysis
10.3.1. Mergers & Acquisitions
10.3.2. New Product Launches
10.3.3. Business Expansions
10.3.4. Partnerships, Agreements & Collaborations
11. Company Usability Profiles
11.1. Benecard Services, LLC
11.1.1. Overview
11.1.2. FPNV Scorecard
11.1.3. SWOT Analysis
11.1.4. Strategy
11.2. CVS Health Corporation
11.2.1. Overview
11.2.2. FPNV Scorecard
11.2.3. SWOT Analysis
11.2.4. Strategy
11.3. DST Systems, Inc.
11.3.1. Overview
11.3.2. FPNV Scorecard
11.3.3. SWOT Analysis
11.3.4. Strategy
11.4. Express Scripts Holding Company
11.4.1. Overview
11.4.2. FPNV Scorecard
11.4.3. SWOT Analysis
11.4.4. Strategy
11.5. Rite Aid Corporation
11.5.1. Overview
11.5.2. FPNV Scorecard
11.5.3. SWOT Analysis
11.5.4. Strategy
11.6. BioScrip, Inc.
11.6.1. Overview
11.6.2. FPNV Scorecard
11.6.3. SWOT Analysis
11.6.4. Strategy
11.7. Change Healthcare, Inc.
11.7.1. Overview
11.7.2. FPNV Scorecard
11.7.3. SWOT Analysis
11.7.4. Strategy
11.8. CVS Caremark
11.8.1. Overview
11.8.2. FPNV Scorecard
11.8.3. SWOT Analysis
11.8.4. Strategy
11.9. Express Scripts Holding Company
11.9.1. Overview
11.9.2. FPNV Scorecard
11.9.3. SWOT Analysis
11.9.4. Strategy
11.10. Magellan Health, Inc.
11.10.1. Overview
11.10.2. FPNV Scorecard
11.10.3. SWOT Analysis
11.10.4. Strategy
11.11. MedImpact Healthcare Systems, Inc.
11.11.1. Overview
11.11.2. FPNV Scorecard
11.11.3. SWOT Analysis
11.11.4. Strategy
11.12. OptumRx
11.12.1. Overview
11.12.2. FPNV Scorecard
11.12.3. SWOT Analysis
11.12.4. Strategy
11.13. Prime Therapeutics LLC
11.13.1. Overview
11.13.2. FPNV Scorecard
11.13.3. SWOT Analysis
11.13.4. Strategy
11.14. Prime Therapeutics LLC
11.14.1. Overview
11.14.2. FPNV Scorecard
11.14.3. SWOT Analysis
11.14.4. Strategy
11.15. ProCare
11.15.1. Overview
11.15.2. FPNV Scorecard
11.15.3. SWOT Analysis
11.15.4. Strategy
11.16. UnitedHealth Group
11.16.1. Overview
11.16.2. FPNV Scorecard
11.16.3. SWOT Analysis
11.16.4. Strategy
12. Appendix
12.1. Industry Experts
12.2. Discussion Guide
12.3. Intellect: 360iResearch Subscription Portal
12.4. Related Reports
12.5. Author Details